IMV
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch IMV and buy or sell other stocks, ETFs, and their options commission-free!About IMV
IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response.
CEOAndrew Hall
CEOAndrew Hall
Employees—
Employees—
HeadquartersDartmouth, Nova Scotia
HeadquartersDartmouth, Nova Scotia
Founded2007
Founded2007
Employees—
Employees—
IMV Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.01
52 Week high$0.01
52 Week low—
52 Week low—
People also own
Based on the portfolios of people who own IMV. This list is generated using Robinhood data, and it’s not a recommendation.